{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:01:27Z","timestamp":1760547687825},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1007\/s00296-004-0466-9","type":"journal-article","created":{"date-parts":[[2004,3,31]],"date-time":"2004-03-31T10:57:11Z","timestamp":1080730631000},"page":"423-428","source":"Crossref","is-referenced-by-count":21,"title":["Hyperhomocysteinemia in patients with Beh\u00e7et\u2019s disease: is it due to inflammation or therapy?"],"prefix":"10.1007","volume":"25","author":[{"given":"Zeki","family":"Yesilova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Pay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cagatay","family":"Oktenli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Musabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Yavuz","family":"Sanisoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal","family":"Dagalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Kemal","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail H.","family":"Kocar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,1]]},"reference":[{"key":"466_CR1","first-page":"1152","volume":"105","author":"Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H (1937) Ueber rezidivierende Aphtoese, durch ein Virus verursachte Geschwuere am Mund, am Auge, und an den Genitalien. Dermatol Wochenschr 105:1152","journal-title":"Dermatol Wochenschr"},{"key":"466_CR2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.55.2.128","volume":"55","author":"Sahin","year":"1996","unstructured":"Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R (1996) Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Beh\u00e7et\u2019s disease. Ann Rheum Dis 55:128\u2013133","journal-title":"Ann Rheum Dis"},{"key":"466_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(21)01067-X","volume":"16","author":"O\u2019Duffy","year":"1990","unstructured":"O\u2019Duffy JD (1990) Vasculitis in Beh\u00e7et\u2019s disease. Rheum Dis Clin North Am 16:423\u2013431","journal-title":"Rheum Dis Clin North Am"},{"key":"466_CR4","first-page":"402","volume":"19","author":"Koc","year":"1992","unstructured":"Koc Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, Batman F, Kansu T, Balkanci F, Akkaya S (1992) Vascular involvement in Beh\u00e7et\u2019s disease. J Rheumatol 19:402\u2013410","journal-title":"J Rheumatol"},{"key":"466_CR5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","volume":"35","author":"Gul","year":"1996","unstructured":"Gul A, Ozbek U, Ozturk C, Inanc M, Konice M, Ozcelik T (1996) Coagulation factor V mutation increases the risk of venous thrombosis in Beh\u00e7et\u2019s disease. Br J Rheumatol 35:1178\u20131180","journal-title":"Br J Rheumatol"},{"key":"466_CR6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/BF00299119","volume":"18","author":"Kuzu","year":"1994","unstructured":"Kuzu MA, Ozaslan C, Koksoy C, Gurler A, Tuzuner A (1994) Vascular involvement in Beh\u00e7et\u2019s disease: 8-year audit. World J Surg 18:948\u2013954","journal-title":"World J Surg"},{"key":"466_CR7","first-page":"305","volume":"14","author":"Yazici","year":"1987","unstructured":"Yazici H, Hekim N, Ozbakir F, Yurdakul S, Tuzun Y, Pazarli H, Muftuoglu A (1987) Von Willebrand factor in Beh\u00e7et\u2019s disease. J Rheumatol 14:305\u2013306","journal-title":"J Rheumatol"},{"key":"466_CR8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","volume":"106","author":"Lee","year":"2002","unstructured":"Lee YJ, Kang SW, Yang JI, Choi Y, Sheen D, Lee EB, Choi S, Song YW (2002) Coagulation parameters and plasma total homocysteine levels in Beh\u00e7et\u2019s disease. Thromb Res 106:19\u201324","journal-title":"Thromb Res"},{"key":"466_CR9","first-page":"111","volume":"56","author":"McCully","year":"1969","unstructured":"McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111\u2013128","journal-title":"Am J Pathol"},{"key":"466_CR10","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg I (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693\u20132698","journal-title":"JAMA"},{"key":"466_CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1172\/JCI108520","volume":"58","author":"Harker","year":"1976","unstructured":"Harker LA, Ross R, Slichter SJ, Scott CR (1976) Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58:731\u2013741","journal-title":"J Clin Invest"},{"key":"466_CR12","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI116532","volume":"91","author":"Hajjar","year":"1993","unstructured":"Hajjar KA (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91:2873\u20132879","journal-title":"J Clin Invest"},{"key":"466_CR13","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/01.ATV.17.10.2074","volume":"17","author":"Majors","year":"1997","unstructured":"Majors A, Ehrhart LA, Pezacka EH (1997) Homocysteine as a risk factor vascular disease: enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 17:2074\u20132081","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"466_CR14","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","volume":"272","author":"Upchurch","year":"1997","unstructured":"Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012\u201317017","journal-title":"J Biol Chem"},{"key":"466_CR15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"Welch","year":"1998","unstructured":"Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042\u20131050","journal-title":"N Engl J Med"},{"key":"466_CR16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJM197409122911101","volume":"291","author":"Harker","year":"1974","unstructured":"Harker LA, Slichter SJ, Scott CR, Ross R (1974) Homocysteinemia. Vascular injury and arterial thrombosis. N Engl J Med 291:537\u2013543","journal-title":"N Engl J Med"},{"key":"466_CR17","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.162.3857.1007-a","volume":"162","author":"Ratnoff","year":"1968","unstructured":"Ratnoff OD (1968) Activation of Hageman factor by L-homocysteine. Science 162:1007\u20131009","journal-title":"Science"},{"key":"466_CR18","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1172\/JCI112519","volume":"77","author":"Rodgers","year":"1986","unstructured":"Rodgers GM, Kane WH (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909\u20131916","journal-title":"J Clin Invest"},{"key":"466_CR19","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI115514","volume":"88","author":"Lentz","year":"1991","unstructured":"Lentz SR, Sadler JE (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88:1906\u20131914","journal-title":"J Clin Invest"},{"key":"466_CR20","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI116712","volume":"92","author":"Nishinaga","year":"1993","unstructured":"Nishinaga M, Ozawa T, Shimada K (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 92:1381\u20131386","journal-title":"J Clin Invest"},{"key":"466_CR21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI118383","volume":"97","author":"Tsai","year":"1996","unstructured":"Tsai JC, Wang H, Perrella MA, Yoshizumi M, Sibinga NE, Tan LC, Haber E, Chang TH, Schlegel R, Lee ME (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97:146\u2013153","journal-title":"J Clin Invest"},{"key":"466_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI118776","volume":"98","author":"Loscalzo","year":"1996","unstructured":"Loscalzo J (1996) The oxidant stress of hyperhomocysteinemia. J Clin Invest 98:5\u20137","journal-title":"J Clin Invest"},{"key":"466_CR23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0024-3205(95)02009-8","volume":"57","author":"Frauscher","year":"1995","unstructured":"Frauscher G, Karnaukhova E, Muehl A, Hoeger H, Lubec B (1995) Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid\u2014additional mechanisms in homocysteine induced endothelial damage? Life Sci 57:813\u2013817","journal-title":"Life Sci"},{"key":"466_CR24","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"466_CR25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","volume":"422","author":"Araki","year":"1987","unstructured":"Araki A & Sako Y (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromat 422: 43\u201352","journal-title":"J Chromat"},{"key":"466_CR26","unstructured":"Zar JH (1996) Biostatistical Analysis. Prentice Hall"},{"key":"466_CR27","doi-asserted-by":"crossref","unstructured":"Armitage B, Berry G, Matthews JNS (2002) Statistical methods in medical research. Blackwell Science, London","DOI":"10.1002\/9780470773666"},{"key":"466_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.RHU.0000049720.44968.EA","volume":"9","author":"Nalbant","year":"2003","unstructured":"Nalbant S, Aktay D, Cingozbay Y, Top C, Kucukardali Y, Avsar K, Danaci M (2003) Homocysteine and Beh\u00e7et disease. J Clin Rheumatol 9:65\u201366","journal-title":"J Clin Rheumatol"},{"key":"466_CR29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/rheumatology\/40.6.687","volume":"40","author":"Aksu","year":"2001","unstructured":"Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapcioglu G, Gumusdis G, Bayindir O, Doganavsargil E (2001) Hyperhomocysteinemia in Beh\u00e7et\u2019s disease. Rheumatology 40:687\u2013690","journal-title":"Rheumatology"},{"key":"466_CR30","first-page":"30","volume":"20","author":"Korkmaz","year":"2002","unstructured":"Korkmaz C, Bozan B, Kosar M, Sahin F, Gulbas Z (2002) Is there an association of plasma homocysteine levels with vascular involvement in patients with Beh\u00e7et\u2019s syndrome? Clin Exp Rheumatol 20:30\u201334","journal-title":"Clin Exp Rheumatol"},{"key":"466_CR31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/bjo.86.6.653","volume":"86","author":"Er","year":"2002","unstructured":"Er H, Evereklioglu C, Cumurcu T, Turkoz Y, Ozerol E, Sahin K, Doganay S (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Beh\u00e7et\u2019s disease. Br J Ophthalmol 86:653\u2013657","journal-title":"Br J Ophthalmol"},{"key":"466_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0009-8981(02)00385-6","volume":"329","author":"Bekpinar","year":"2003","unstructured":"Bekpinar S, Kocak H, Unlucerci Y, Genc S, Akdag KA, Gogus F (2003) The evaluation of C-reactive protein, homocysteine and vitamin B6 concentrations in Beh\u00e7et and rheumatoid arthritis disease. Clin Chim Acta 329:143\u2013145","journal-title":"Clin Chim Acta"},{"key":"466_CR33","first-page":"931","volume":"4","author":"Okka","year":"2002","unstructured":"Okka M, Ozturk M, Kockar MC, Bavbek N, Rasier Y, Gunduz K, Korkar MC (2002) Plasma homocysteine level and uveitis in Beh\u00e7et\u2019s disease. Isr Med Assoc J 4:931\u2013934","journal-title":"Isr Med Assoc J"},{"key":"466_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.60.1.65","volume":"60","author":"Fresko","year":"2001","unstructured":"Fresko I, Hamuryudan V, Demir M, Hizli N, Sayman H, Melikoglu M, Tunc R, Yurdakul S, Yazici H (2001) Intestinal permeability in Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 60:65\u201366","journal-title":"Ann Rheum Dis"},{"key":"466_CR35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-4362.1986.tb02232.x","volume":"25","author":"Muftuoglu","year":"1986","unstructured":"Muftuoglu AU, Yazici H, Yurdakul S, Tuzun Y, Pazarli H, Gungen G, Deniz S (1986) Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 25:235\u2013239","journal-title":"Int J Dermatol"},{"key":"466_CR36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0021-9150(03)00161-8","volume":"169","author":"Folsom","year":"2003","unstructured":"Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE (2003) B vitamin status and inflammatory markers. Atherosclerosis 169:169\u2013174","journal-title":"Atherosclerosis"},{"key":"466_CR37","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1055\/s-0038-1665406","volume":"78","author":"de","year":"1997","unstructured":"de Jong SC, Stehouwer CD, van den Berg M, Vischer UM, Rauwerda JA, Emeis JJ (1997) Endothelial marker proteins in hyperhomocysteinemia. Thromb Haemost 78:1332\u20131337","journal-title":"Thromb Haemost"},{"key":"466_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/03009740310003686","volume":"32","author":"Yxfeldt","year":"2003","unstructured":"Yxfeldt A, Wallberg-Jonsson S, Hultdin J, Rantapaa-Dahlqvist S (2003) Homocysteine in a patient with rheumatoid arthritis in relation to inflammation and B-vitamin treatment. Scand J Rheumatol 32:205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"466_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-9343(02)01528-0","volume":"114","author":"Chiang","year":"2003","unstructured":"Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R (2003) Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 114:283\u2013287","journal-title":"Am J Med"},{"key":"466_CR40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.98.3.196","volume":"98","author":"Kuller","year":"1998","unstructured":"Kuller LH, Evans RW (1998) Homocysteine, vitamins, and cardiovascular disease. Circulation 98:196\u2013199","journal-title":"Circulation"},{"key":"466_CR41","first-page":"227","volume":"9","author":"Pronai","year":"1991","unstructured":"Pronai L, Ichikawa Y, Nakazawa H, Arimory S (1991) Enhanced superoxide generation and the decreased superoxide scavenging activity of peripheral blood leukocytes in Beh\u00e7et\u2019s disease: effects of colchicine. Clin Exp Rheum 9:227\u2013233","journal-title":"Clin Exp Rheum"},{"key":"466_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0923-1811(97)00613-0","volume":"16","author":"Orem","year":"1997","unstructured":"Orem A, Efe H, Deger O, Cimsit G, Uydu HA, Vanizor B (1997) Relationship between lipid peroxidation and disease activity in patients with Beh\u00e7et\u2019s disease. J Dermatol Sci 16:11\u201316","journal-title":"J Dermatol Sci"},{"key":"466_CR43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-9120(01)00190-4","volume":"34","author":"Kose","year":"2001","unstructured":"Kose K, Yazici C, Ascioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Beh\u00e7et\u2019s disease. Clin Biochem 34:125\u2013129","journal-title":"Clin Biochem"},{"key":"466_CR44","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/ndt\/16.11.2172","volume":"16","author":"Bayes","year":"2001","unstructured":"Bayes B, Pastor MC, Bonal J, Junca J, Romero R (2001) Homocysteine and lipid peroxidation in hemodialysis: role of folic acid and vitamin E. Nephrol Dial Transplant 16:2172\u20132175","journal-title":"Nephrol Dial Transplant"},{"key":"466_CR45","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","volume":"20","author":"Memon","year":"2000","unstructured":"Memon RA, Staprans I, Noor M, Holleran WM, Uchida Y, Moser AH, Feingold KR, Grunfeld C (2000) Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol 20:1536\u20131542","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"466_CR46","first-page":"247","volume":"49","author":"Niwa","year":"1982","unstructured":"Niwa Y, Miyake S, Sakane T, Shingen M, Yokoyama M (1982) Auto-oxidative damage in Beh\u00e7et\u2019s disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247\u2013255","journal-title":"Clin Exp Immunol"},{"key":"466_CR47","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.ATV.0000013288.35930.90","volume":"22","author":"Holven","year":"2002","unstructured":"Holven K, Aukrust P, Holm T, Ose L, Nenseter M (2002) Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 22:699\u2013703","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"466_CR48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00007890-199602150-00034","volume":"61","author":"Arnadottir","year":"1996","unstructured":"Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H (1996) Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 61: 509\u2013512","journal-title":"Transplantation"},{"key":"466_CR49","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/clinchem\/44.11.2307","volume":"44","author":"Cole","year":"1998","unstructured":"Cole DEC, Ross HJ, Evrovski J, Langman LJ, Miner SES, Daly PA, Wong PY (1998) Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients. Clin Chem 44:2307\u20132312","journal-title":"Clin Chem"},{"key":"466_CR50","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1046\/j.1523-1755.1998.00112.x","volume":"54","author":"Arnadottir","year":"1998","unstructured":"Arnadottir M, Hultberg B, Wahlberg J, Fellstr\u00f6m B, Dimeny E (1998) Serum total homocysteine concentration before and after renal transplantation. Kidney Int 54: 1380\u20131384","journal-title":"Kidney Int"},{"key":"466_CR51","first-page":"232","volume":"49","author":"Ducloux","year":"1998","unstructured":"Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM (1998) Hyperhomocysteinemia in renal transplant recipients with and without cyclosporine. Clin Nephrol 49:232\u2013235","journal-title":"Clin Nephrol"},{"key":"466_CR52","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1093\/ndt\/13.11.2890","volume":"13","author":"Ducloux","year":"1998","unstructured":"Ducloux D, Ruedin C, Gibey R, Chalopin JM (1998) Prevalence, determinants, and clinical significance of hyperhomocysteinemia in renal-transplant recipients. Nephrol Dial Transplant 13:2890","journal-title":"Nephrol Dial Transplant"},{"key":"466_CR53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0009-8981(99)00023-6","volume":"282","author":"Woodside","year":"1999","unstructured":"Woodside JV, Fogarty DG, Lightbody JH, Loughrey CM, Yarnell JW, Maxwell AP, Young IS (1999) Homocysteine and B- group vitamins in renal transplant patients. Clin Chim Acta 282:157\u2013166","journal-title":"Clin Chim Acta"},{"key":"466_CR54","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00007890-199802270-00016","volume":"65","author":"Gupta","year":"1998","unstructured":"Gupta A, Moustapha A, Jacobsen DW, Goormastic M, Tuzcu EM, Hobbs R, Young J, James K, McCarthy P, van Lente F, Green R, Robinson K (1998) High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 65:544\u2013550","journal-title":"Transplantation"},{"key":"466_CR55","first-page":"1931","volume":"7","author":"Fogarty","year":"1996","unstructured":"Fogarty DG, Woodside J, Lightbody JM, Maxwell AP (1996) Plasma homocysteine in renal transplant recipients. J Am Soc Nephrol 7:1931","journal-title":"J Am Soc Nephrol"},{"key":"466_CR56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1399-0012.2000.140202.x","volume":"14","author":"Fernandez-Miranda","year":"2000","unstructured":"Fernandez-Miranda C, Gomez P, Diaz-Rubio P, Estenoz J, Carrillo JL, Andres A, Morales JM (2000) Plasma homocystenie levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Clin Transplant 14:110\u2013114","journal-title":"Clin Transplant"},{"key":"466_CR57","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0041-1345(00)01473-1","volume":"32","author":"Kim","year":"2000","unstructured":"Kim SI, Yoo TH, Song HY, Hwang JH, Lee HY, Han DS, Moon JI, Kim YS, Park KI, Paenk KJ, Choi KH. (2000) Hyperhomocysteinemia in renal transplant recipients with cyclosporine. Transplant Proceed 32:1878\u20131879","journal-title":"Transplant Proceed"},{"key":"466_CR58","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1046\/j.1523-1755.2001.59780262.x","volume":"78","author":"Stein","year":"2001","unstructured":"Stein G, Muller A, Busch M, Fleck C, Sperschneider H (2001) Homocysteine, its metabolites, and B-group vitamins in renal transplant patients. Kidney Int 78: S262-S265","journal-title":"Kidney Int"},{"key":"466_CR59","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0041-1345(02)03075-0","volume":"34","author":"Mehra","year":"2002","unstructured":"Mehra MR, Uber PA, Scott RL, Park MH, Milani RV (2002) Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, C-reactive protein, and mean platelet volume. Transplant Proceed 34:1866\u20131868","journal-title":"Transplant Proceed"},{"key":"466_CR60","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1046\/j.1523-1755.59.s78.1.x","volume":"59","author":"Ignatescu","year":"2001","unstructured":"Ignatescu M, Fodinger M, Kletzmayr J, Bieglmayer C, Horl W, Sunder-Plassmann G (2001) Is there a role of cyclosporine A on total homocysteine export from human renal proximal tubular epithelial cells? Kidney Int 59: S258-S261","journal-title":"Kidney Int"},{"key":"466_CR61","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0041-1345(03)00076-9","volume":"35","author":"Hultberg","year":"2003","unstructured":"Hultberg B, Arnadottir M (2003) The effect of cyclosporine on homocysteine export in human cell lines. Transplant Proceed 35:801\u2013802","journal-title":"Transplant Proceed"},{"key":"466_CR62","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1523-1755.1999.0550031072.x","volume":"55","author":"Fodinger","year":"1999","unstructured":"Fodinger M, Wolfl G, Fischer G, Rasoul-Rockenschaub S, Schmid R, Horl WH, Sunder-Plassmann G (1999) Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int 55: 1072\u20131080","journal-title":"Kidney Int"},{"key":"466_CR63","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/01.ATV.17.10.1894","volume":"17","author":"Bostom","year":"1997","unstructured":"Bostom AG, Gohh RY, Tsai MY, Hopkins-Garcia BJ, Nadeau MR, Bianchi LA, Jacques PF, Rosenberg IH, Selhub J (1997) Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal recipients. Arterioscler Thromb Vasc Biol 17:1894\u20131900","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"466_CR64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0026-0495(97)90248-1","volume":"46","author":"Kim","year":"1997","unstructured":"Kim MH, Kim E, Passen EL, Meyer J, Kang SS (1997) Cortisol and estradiol: nongenetic factors for hyperhomocysteinemia. Metabolism 46:247\u2013249","journal-title":"Metabolism"},{"key":"466_CR65","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/ard.62.7.694","volume":"62","author":"Lazzerini","year":"2003","unstructured":"Lazzerini PE, Capecchi PL, Bisogno S, Galeazzi M, Marcolonga R, Laghi Pasini F (2003) Reduction in plasma homocysteine level in patients with rheumatoid arthritis given pulsed glucocorticoid treatment. Ann Rheum Dis 62:694\u2013695","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-004-0466-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0466-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T20:31:17Z","timestamp":1705091477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-004-0466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s00296-004-0466-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}